Intrauterine misoprostol for the prevention of bleeding cesarean;Misoprostol intrauterino para la prevención de la hemorragia postcesárea

Ginecologia y Obstetricia de Mexico

Volumn 77, Issue 10, 2009, Pages 469-474

  Quiroga Díaz, Ricardo ^a   Cantú Mata, Reynaldo ^a   Tello Gutiérrez, Héctor E ^a   Puente Villalobos, Mireya ^a   Montemayor Garza, Rogelio ^a   Martínez Mendoza, Araceli ^a  

^a Hospital de Ginecología Y Obstetricia de Monterrey   (Mexico)

Author keywords

Misoprostol; Oxitocin; Postcaesarean sanguineous loss

Indexed keywords

HEMOGLOBIN; MISOPROSTOL; OXYTOCIN; PLACEBO; OXYTOCIC AGENT;

ADULT; ARTICLE; CESAREAN SECTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; FEMALE; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; NAUSEA; OBSTETRIC HEMORRHAGE; PAIN; RANDOMIZED CONTROLLED TRIAL; VOMITING; DOUBLE BLIND PROCEDURE; POSTOPERATIVE HEMORRHAGE; POSTPARTUM HEMORRHAGE; PREGNANCY; UTERUS;

ADULT; CESAREAN SECTION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MISOPROSTOL; OXYTOCICS; POSTOPERATIVE HEMORRHAGE; POSTPARTUM HEMORRHAGE; PREGNANCY; UTERUS;

EID: 73949111101     PISSN: 03009041     EISSN: 03009041     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Printchard JA, Baldwin RM, Dicker JC, Wiggins KM. Blood volumen changes in pregnancy and the puerperium. Am J Obstet Gynecol 1962;84:1271-82.
2. Clark SL, Yeh SY, Phelan JP, Bruce S, Paul RH. Emergency hysterectomy for obstetric hemorrhage. Obstet Gynecol 1984;64:376-80.
3. Fernández CS. Índices de mortalidad materna. Dirección General de Estadística e Informática. Secretaría de Salud. México, 1990-1996.
4. Turmen T. Safe motherhood: a global problem. Report from a symposium on the prevention and management of anaemia in pregnancy and postpartum hemorrhage. World Health Organization. Zurich, 1996:1-13.
5. Drife J. Management of primary postpartum haemorrhage (commentary). Br J Obstet Gynaecol 1997;104:275-7.
6. Hogerzeil HV, Walker GJA, de Goeje MJ. Stability of injectable oxytocics in tropical climates. Geneva: World Health Organization, 1993.
7. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin: Clinical Management Guidelines for Obstetrician-Gynecologists Number 76, October 2006: postpartum hemorrhage. Obstet Gynecol 2006;108:1039-47
8. Pendiville WL, Harding JE, Elbourne DR, Stirrat GM. The Bristol third stage trial:actives versus physiological management of third stage of labour. BMJ 1988;197:1295-300.
9. el-Refaey H, Hinshaw K, Templeton A. The abortifacient effect of misoprostol in the second trimester. Hum Reprod 1993;8:1744-6.
10. Sánchez-Ramos L, Kaunitz AM. Misoprostol for cervical ripening and labor induction; a systematic review of the literature. Clin Obstet Gynecol 2000;43:475-88.
11. el-Refaey H, O'Brien P, Morafa W, Walder J, Rodeck C. Use of oral misoprostol in the prevention of postpartum haemorrhage. Br J Obstet Gynaecol 1997;104;336-9.
12. Bamigboye AA, Hofmeyr GJ, Merrell DA. Coronation Hospital Johannesburg, South Africa. Rectal misoprostol in the prevention of postpartum hemorrhage. Am J Obstet Gynaecol 1998:179;1043-6.
13. Quiroga DR, Esparza AM. Misoprostol vaginal para la prevención de la hemorragia posparto. Ginecol Obstet Mex 2002;70:572-5.